Want to join the conversation?
$MYL announced U.S. launch of Dutasteride Capsules, 0.5 mg, generic version of $GSK's Avodart Capsules. Mylan received final FDA approval for this product, which is indicated as monotherapy for treatment of symptomatic benign prostatic hyperplasia (BPH) in men with enlarged prostate to improve symptoms, reduce risk of acute urinary retention.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?